Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.82 USD | +1.85% | +2.66% | +37.52% |
May. 10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
May. 09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.52% | 3.78B | |
+29.74% | 48.16B | |
-1.23% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+9.88% | 25.59B | |
-23.07% | 18.96B | |
+8.40% | 12.92B | |
+28.92% | 12.03B | |
-2.12% | 11.77B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Transcript : Crinetics Pharmaceuticals, Inc. - Special Call